Literature DB >> 20513121

Serum immunoglobulin free light chain measurements and heavy chain isotype usage provide insight into disease biology in patients with POEMS syndrome.

Trista Stankowski-Drengler1, Morie A Gertz, Jerry A Katzmann, Martha Q Lacy, Shaji Kumar, Nelson Leung, Suzanne R Hayman, Francis Buadi, Robert A Kyle, S Vincent Rajkumar, Angela Dispenzieri.   

Abstract

POEMS (polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, skin changes) syndrome is a rare paraneoplastic syndrome in which nearly all patients have a monoclonal lambda restricted plasma cell disorder. We investigated whether patients with POEMS have abnormal serum immunoglobulin free light chain (FLC) ratios. Fifty patients with newly diagnosed POEMS syndrome were assessed. Cystatin C levels were measured to discern whether subclinical renal insufficiency could account for FLC elevations in the presence of a normal FLC ratio. Forty-five patients (90%) had elevated lambda FLC; however, only nine (18%) had abnormal FLC ratios. The rise in serum FLC of POEMS patients appeared to be multifactorial-both a function of subclinical renal insufficiency and polyclonal activation of medullary and extramedullary plasma cells. Those patients expressing a clonal IgA were more likely to have clonal plasmacytosis observed on iliac crest biopsy than those with IgG. In summary, serum immunoglobulin profiles are unique in POEMS syndrome as compared with other plasma cell disorders. 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20513121      PMCID: PMC2902776          DOI: 10.1002/ajh.21707

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  13 in total

1.  Highly sensitive, automated immunoassay for immunoglobulin free light chains in serum and urine.

Authors:  A R Bradwell; H D Carr-Smith; G P Mead; L X Tang; P J Showell; M T Drayson; R Drew
Journal:  Clin Chem       Date:  2001-04       Impact factor: 8.327

2.  Presence of monoclonal free light chains in the serum predicts risk of progression in monoclonal gammopathy of undetermined significance.

Authors:  S Vincent Rajkumar; Robert A Kyle; Terry M Therneau; Raynell J Clark; Arthur R Bradwell; L Joseph Melton; Dirk R Larson; Matthew F Plevak; Jerry A Katzmann
Journal:  Br J Haematol       Date:  2004-11       Impact factor: 6.998

3.  Serum free light-chain measurements for identifying and monitoring patients with nonsecretory multiple myeloma.

Authors:  M Drayson; L X Tang; R Drew; G P Mead; H Carr-Smith; A R Bradwell
Journal:  Blood       Date:  2001-05-01       Impact factor: 22.113

4.  Serum immunoglobulin free light chain assessment in rheumatoid arthritis and primary Sjogren's syndrome.

Authors:  J-E Gottenberg; F Aucouturier; J Goetz; C Sordet; I Jahn; M Busson; J-M Cayuela; J Sibilia; X Mariette
Journal:  Ann Rheum Dis       Date:  2006-03-28       Impact factor: 19.103

Review 5.  Biochemistry and clinical role of human cystatin C.

Authors:  Michele Mussap; Mario Plebani
Journal:  Crit Rev Clin Lab Sci       Date:  2004       Impact factor: 6.250

6.  Are renal reference intervals required when screening for plasma cell disorders with serum free light chains and serum protein electrophoresis?

Authors:  Jude M Abadie; K H van Hoeven; Justin M Wells
Journal:  Am J Clin Pathol       Date:  2009-02       Impact factor: 2.493

7.  Quantitative analysis of serum free light chains. A new marker for the diagnostic evaluation of primary systemic amyloidosis.

Authors:  Roshini S Abraham; Jerry A Katzmann; Raynell J Clark; A R Bradwell; Robert A Kyle; Morie A Gertz
Journal:  Am J Clin Pathol       Date:  2003-02       Impact factor: 2.493

Review 8.  POEMS syndrome.

Authors:  Angela Dispenzieri
Journal:  Blood Rev       Date:  2007-09-11       Impact factor: 8.250

9.  Immunoglobulin free light chain ratio is an independent risk factor for progression of smoldering (asymptomatic) multiple myeloma.

Authors:  Angela Dispenzieri; Robert A Kyle; Jerry A Katzmann; Terry M Therneau; Dirk Larson; Joanne Benson; Raynell J Clark; L Joseph Melton; Morie A Gertz; Shaji K Kumar; Rafael Fonseca; Diane F Jelinek; S Vincent Rajkumar
Journal:  Blood       Date:  2007-10-17       Impact factor: 22.113

10.  Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains.

Authors:  Jerry A Katzmann; Raynell J Clark; Roshini S Abraham; Sandra Bryant; James F Lymp; Arthur R Bradwell; Robert A Kyle
Journal:  Clin Chem       Date:  2002-09       Impact factor: 8.327

View more
  7 in total

1.  Immunoglobulin variable domain high-throughput sequencing reveals specific novel mutational patterns in POEMS syndrome.

Authors:  Sébastien Bender; Vincent Javaugue; Alexis Saintamand; Maria Victoria Ayala; Mehdi Alizadeh; Matthieu Filloux; Virginie Pascal; Nathalie Gachard; David Lavergne; Fabienne Auroy; Michel Cogné; Frank Bridoux; Christophe Sirac; Arnaud Jaccard
Journal:  Blood       Date:  2020-05-14       Impact factor: 22.113

Review 2.  How I treat POEMS syndrome.

Authors:  Angela Dispenzieri
Journal:  Blood       Date:  2012-04-30       Impact factor: 22.113

3.  Pulmonary hypertension in POEMS syndrome: resolution following radiotherapy.

Authors:  Melanie J Brewis; Alistair C Church; Andrew J Peacock; Stephen Thomson; Jane Tighe; Martin K Johnson
Journal:  Pulm Circ       Date:  2014-12       Impact factor: 3.017

4.  Biclonal Gammopathy as a Misleading Indicator to Diagnose POEMS Syndrome: An Autopsy Case Report and a Review of the Literature.

Authors:  Shizuko Ainai; Ryouhei Komaki; Naokazu Muramae; Rena Uno; Kenta Mori; Kazunori Otsui; Kimikazu Yakushijin; Kazuhiko Sakaguchi
Journal:  Cureus       Date:  2022-05-20

5.  Polyneuropathy as Novel Initial Manifestation in a Case of "Nonsecretory" POEMS Syndrome with Sjögren's Syndrome.

Authors:  Minrui Liang; Zhixing Jiang; Zhiguang Lin; Bobin Chen; Hejian Zou; Weiguo Wan; Jun Liu
Journal:  Case Rep Med       Date:  2017-01-04

6.  Raised VEGF: High sensitivity and specificity in the diagnosis of POEMS syndrome.

Authors:  Morgane Pihan; Stephen Keddie; Shirley D'Sa; Andrew J Church; Kwee L Yong; Mary M Reilly; Michael P Lunn
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2018-08-15

Review 7.  POEMS SYNDROME: an Update.

Authors:  Andrea Nozza
Journal:  Mediterr J Hematol Infect Dis       Date:  2017-09-01       Impact factor: 2.576

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.